What
unexpected or serendipitous events arose in the course of your
research?
Back in the 1980s, my colleagues and I in London performed a study of
depressive disorder which found that not only did depression run in
families but so too did 'bad luck' or unpleasant events. This seemed
most surprising at the time but was soon followed by twin studies
elsewhere that found much the same, and in fact, showed that for
some categories of life events there is probably a genetic
contribution. A recent study of twins
in Wales by Anita Thapar and
myself suggested 'cognitive' explanation that part of this is the
way people see and report on their world. Other work, for example by
my colleague Robert Plomin, suggests that some people create events
and/or tend to find their way into hazardous situations. I, however,
still favored a cognitive view and predicted that the most recent
study by Anne Farmer would find positive correlations between
siblings even for severe independent events. It did, but this was
entirely explained by the same events affecting both sibs. Not the
result I'd expected, but a family event. Anne is my wife.
What
role did practical support (facilities, funding, etc.) play?
I've been fortunate throughout my research career in receiving
grant support from the UK Medical Research Council (MRC). Without
this, most of my work, from my beginnings in full time research as a
training fellow through to my present job as director of an MRC
center, would have been impossible. Of course other grant-giving
bodies, including the Wellcome Trust and NIH, have also been
important and most recently, the UK government/Wellcome Trust Joint
Infrastructure Fund has provided us the money for a new building
which will bring together our Center’s offices and labs, which are
currently dispersed across 7 different buildings on the Maudsley
Hospital/Institute of Psychiatry campus. This will be a great boost
toward achieving the Center mission of fully integrating our
research on the whole range causal factors in psychiatric disorders
and associated traits, from social through to molecular genetics.
How
do you see the current state of affairs in your field and its
prospects for the future?
This is an exciting period in psychiatry. There is now general
acceptance, as a result of family, twin, and adoption studies, that
genes have an important role in most mental disorders but so too
does the environment. Our work is therefore to try to understand
gene- environment interplay as well as to locate and identify the
genes and discover how they function. Finding genes has of course
been most straightforward for rare neuropsychiatric disorders such
as Huntington's disease and rare early-onset sub-forms of
Alzheimer's. Some of my colleagues have become exasperated that it
has been far more difficult with common complex conditions like
schizophrenia, where it is now clear that there are no genes of big
effect. However, I remain very optimistic that we will soon locate
genes involved in these polygenic disorders and there are already
replicated findings in conditions such as dyslexia and autism which,
a few years ago, many clinicians hotly denied the existence of any
genetic component.
What
are the implications of your work for the future of your field in
terms of clinical/therapeutic applications/products?
The perception of psychiatry both within and outside the medical
profession will change. In fact this is already happening. A couple
of years ago, I was amused to hear a geneticist colleague remark
that Alzheimer's disease should now be regarded as a neurological,
not a psychiatric disease because study of its genetics and
neurobiological basis was becoming tractable. If we accept that kind
of radical reclassification, the same will be become true of
schizophrenia, autism, bipolar disorder, unipolar depression, and so
on. In terms of reducing stigma this may be beneficial. Years back,
before it was a 'real' disease the relatives of an ex-US president
or of a famous British writer (Iris Murdoch) might have been
reluctant to discuss their Alzheimer's disease publicly. However the
biggest practical long-term benefits which might arise from genetic
research are the discovery of novel targets for new drugs and being
able to tailor the safest, most effective treatments to individual
patients.
What
would you rate as your most difficult or trying professional moment?
In my previous job as chairman of a university department of
psychiatry I had repeated trying moments on the same theme over the
course of 12 years. These had to do with the tension, which often
became severe, between my staff's contribution to a clinical service
and their ability to deliver on their research and teaching. This
was compounded by the reorganisation of psychiatric service that
accelerated in the 1990s, which led to greater emphasis on care in
the community so that clinical academics no longer could expect
their university base to be alongside their clinics.
Which
of your professional achievements brings you the most satisfaction?
In many ways I am most proud of having built a successful
research led department at the College of Medicine in Cardiff
despite the tensions and trying moments described above.
More specifically on my own research, I'm rather satisfied that
the highly eccentric type of research that I embarked on in the mid
1970s of trying to find genes by linkage and association has now
become an accepted mainstream pursuit which is likely to have big
pay-offs. Along the way some of the more quantitative work on
families and twins that I've done with colleagues such as Irv
Gottesman, Anne Farmer, Anita Thapar, and others has contributed to
understanding about the genetics of common psychiatric disorders and
traits.
Aside
from your scientific career, what is your greatest or most compelling
ambition in life?
- 1. To be a better classical guitarist, but not to be too
disappointed that I'll never be John Williams.
- To be able to compete creditably at dressage at above novice
level.
Would
you like to leave any other comments about your work or share a
personal side of yourself?
I first decided that I wanted to become a psychiatrist at the age
of about 16 after reading Freud’s Introductory Lectures on
Psychoanalysis and thinking ‘Wow! This stuff’s cool’. I
continued to regard Freud as cool when I eventually got to medical
school (itself rather uncool) and then qualified as a doctor. I then
spent a couple of years in internal medicine and became fascinated
with the idea of discovering genetic markers for disease, writing
one of my first papers on HLA and coronary heart disease. This
turned out to be completely negative but I took my genetic interests
with me into my psychiatric training and decided that the study of
genes offered a brighter ‘Royal Road’ to discovering the cause
of my patients’ troubles than analyzing their dreams. Now, quite a
few years on, I would no longer even regard much of Freud’s work
as science and believe that his followers did a good deal of damage
to psychiatry. However he was a seductive writer and I still have a
soft spot for him, but my guess is that had he been born a century
later than he was, he would never have been bothered with all of
that psychodynamic theory; he’d have been down the lab doing
genetics.

Dr. Peter McGuffin
Director and Professor of Psychiatric Genetics,
Social Genetic and Developmental Psychiatry (SGDP) Research Centre,
Institute of Psychiatry,
Kings College London